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Neuropeptides are often released into circulatory fluid (hemolymph) to act as circulating
hormones and regulate many physiological processes. However, the detection of these
low-level peptide hormones in circulation is often complicated by high salt interference and
rapid degradation of proteins and peptides in crude hemolymph extracts. In this study, we
systematically evaluated three different neuropeptide extraction protocols and developed a
simple and effective hemolymph preparation method suitable for MALDI MS profiling of
neuropeptides by combining acid-induced abundant protein precipitation/depletion, ultrafil-
tration, and C18 micro-column desalting. In hemolymph samples collected from the crab Cancer
borealis, several secreted neuropeptides have been detected, including members from at least
five neuropeptide families, such as RFamide, allatostatin, orcokinin, tachykinin-related pep-
tide (TRP), and crustacean cardioactive peptide (CCAP). Furthermore, two TRPs were detected
in the hemolymph collected from food-deprived animals, suggesting the potential role of these
neuropeptides in feeding regulation. In addition, a novel peptide with a Lys-Phe-amide
C-terminus was identified and de novo sequenced directly from the Cancer borealis hemolymph
sample. To better characterize the hemolymph peptidome, we also identified several abundant
peptide signals in C. borealis hemolymph that were assigned to protein degradation products.
Collectively, our study describes a simple and effective sample preparation method for
neuropeptide analysis directly from crude crustacean hemolymph. Numerous endogenous
neuropeptides were detected, including both known ones and new peptides whose functions
remain to be characterized. (J Am Soc Mass Spectrom 2009, 20, 708–718) © 2009 Published by
Elsevier Inc. on behalf of American Society for Mass SpectrometryNeuropeptides are an important class of chemi-cal messengers that modulate nervous systemresponse. These signaling molecules are in-
volved in initiation, modulation, and regulation of
many physiological processes. Often times these pep-
tides need to be secreted into circulating fluids to exert
their hormonal effects on distant organs that participate
in a variety of functions such as food intake, pain
sensing, stress response, and molting, among many
others [1–4]. These peptide hormones have been impli-
cated in regulation of physiological processes, including
the control of heart function, hemolymph circulation,
and digestion, to name a few [5–7]. Monitoring these
released neuropeptides is therefore essential for identi-
fication of bioactive neuropeptides and serves as an
important step towards understanding their functions.
Furthermore, hemolymph serves as an abundant sam-
ple source that can be collected without sacrificing the
animals. Thus, the analysis of hemolymph neuropep-
tide profiles offers a great opportunity to monitor
peptide secretion changes under different physiological
states or in response to different functional manipula-
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doi:10.1016/j.jasms.2008.12.007tions with the usage of the same animal. Consequently,
developing effective and highly sensitive methods to
examine peptide hormones in circulating hemolymph is
an important step toward peptide functional studies.
It has been reported that using traditional immuno-
assays such as radioactive immunoassay (RIA) and
enzyme immunoassay (EIA), several neuropeptides
were found to be circulating hormones in crustacean
hemolymph including crustacean cardioactive peptide
(CCAP) [1], crustacean hyperglycemic hormone (CHH)
and molting-inhibiting hormone (MIH) [8–10]. How-
ever these methods require antibodies, many of which
are not commercially available. Furthermore, they suf-
fer from limitations of cross-reactivity with structurally
similar peptides and inability to analyze multiple pep-
tides simultaneously, which greatly impedes the unam-
biguous identification of neuropeptide isoforms. Since
the last two decades, numerous neuropeptides have
been discovered in crustacean neuronal tissues using
biological mass spectrometry (MS), which provides
high speed, great sensitivity, and chemical specificity
[11–14]. However, compared with the widespread
study of neuropeptides using tissue sources, reports on
peptide analysis of hemolymph have been quite scarce,
which is in part due to the significant analytical chal-
lenges for peptide detection in these complex biological
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ber of abundant proteins including haemocyanin, cryp-
tocyanin, plasma coagulogen, heteroagglutinins, and
vitellogenins, among others [15, 16]. These proteins can
degrade into small fragments under natural conditions
or during sample processing, which not only sup-
presses the detection of low-abundance peptide hor-
mones but also complicates data analysis of the hemo-
lymph peptidome. Furthermore, the circulating peptide
hormones are present at extremely low concentrations
(pM-nM) [17], which is in contrast with the high salt
concentrations (500 mM) inherent to marine organ-
isms that interferes with mass spectrometric analysis of
neuropeptides. Therefore, developing advanced sample
preparation method is a key to improve the sensitivity
and selectivity for detection of putative neuropeptides
in hemolymph.
Recently, Fastner and coworkers detected pre-
ecdysis triggering hormone (PETH) with concentration
of 30 to 45 nM during pre-ecdysis in insect hemolymph
using heat-induced abundant protein depletion, ultra-
filtration, and reversed-phase high-performance liquid
chromatography (RP-HPLC) [17]. In our previous study,
using acidified methanol as extraction buffer, Cancer bo-
realis tachykinin-related peptide (CabTRP) Ia was detected
in hemolymph of Cancer productus under starvation with
accurate massmeasurement viaMALDI-FTMS [18]. How-
ever, no MS/MS data were available to confirm the
identity of the peptide due to its low concentration in the
sample.
This article provides the first description of an effec-
tive sample preparation methods for peptidomic profil-
ing and neuropeptide detection in crustacean hemo-
lymph using MS. In this study, we have developed a
hybrid sample preparation approach combining ultra-
centrifugation to remove the high molecular weight
species and micro-scale solid-phase extraction to extract
and concentrate neuropeptides upon desalting, which
enables effective detection of peptide hormones in the
hemolymph. We systematically investigated three dif-
ferent buffer solutions and two types of protein deple-
tion methods including heat-induced and acid-induced
protein denaturation/precipitation. With the effective
removal of highly abundant proteins, acidified metha-
nol spiked with EDTA and protease inhibitors pro-
duced the best recovery of spiked neuropeptide stan-
dards and yielded sensitive detection of neuropeptides
from hemolymph samples. CabTRP Ia (m/z 934.5) was
detected as a circulating peptide hormone from hemo-
lymph in starved animal with supporting MS/MS in-
formation, suggesting a potential role of this peptide in
feeding regulation. Several additional neuropeptides
were also detected based on accurate mass matching
with previously reported neuropeptides. We also de
novo sequenced a peptide with C-terminal KFamide,
which could be a novel family of neuropeptide(s)
whose function remains to be determined. Some com-
mon protein degradation products present in hemo-lymph were also identified with de novo sequencing
assisted by Mascot database searching and BLAST.
Experimental
Chemicals and Materials
Methanol, acetonitrile, formic acid (FA), acetic acid,
and EDTA disodium salt were purchased from Fisher
Scientific (Pittsburgh, PA); 2,5-dihydroxybenzoic acid
(DHB) was obtained from MP Biomedicals, Inc. (So-
lon, OH); -cyano-4-hydroxy-cinnamic acid (CHCA)
was purchased from Sigma-Aldrich (St. Louis, MO);
protease inhibitor Complete-Mini cocktail was pur-
chased from Roche (Indianapolis, IN); C18 micro spin
column and 10 kDa molecular weight cutoff tube
(MWCO) were purchased from Argos (Elgin, IL).
Acidified methanol was prepared using 90% metha-
nol, 9% glacial acetic acid, and 1% water. All water
used in this study was deionized water from a
Millipore filtration system (Bedford, MA). Peptide
standards: angiotensin II (DRVYIHPF, m/z 1046.5),
bradykinin (RPPGFSPFR m/z 1060.5), [Arg8] vaso-
pressin (AVP) (CYFQNCPRGamide m/z 1084.4),
[Val5] angiotensin I (DRVYVHPFHL m/z 1282.7), an-
giotensin I (DRVYIHPFHL m/z 1296.7), allatostatin I
(APSGAQRLYGFGLamide m/z 1335.7), substance P
(RPKPQQFFGLMamide m/z 1347.7) were purchased
from the American Peptide Company (Sunnyvale, CA).
Instrumentation
MALDI TOF/TOF. A model 4800 MALDI TOF/TOF
analyzer (Applied Biosystems, Framingham, MA)
equipped with a 200 Hz, 355 nm Nd:YAG laser was
used for both direct peptide profiling and tandem MS
fragmentation study for hemolymph samples. Acquisi-
tions were performed in positive ion reflectron mode.
Instrument parameters were set using the 4000 Series
Explorer software (Applied Biosystems). Mass spectra
were obtained by averaging 1000 laser shots covering
mass range m/z 500 to 4000. MS/MS was achieved by
2 kV collision induced dissociation (CID) using air. The
peptide sequences were predicted manually with the help
of de novo Explorer software (Applied Biosystems). A
saturated solution of -cyano-4-hydroxycinnamic acid
(CHCA) in 50% (vol/vol) acetonitrile was used as matrix.
For sample spotting, 0.4 L of sample was spotted on
MALDI plate and allowed to dry, followed by application
of 0.4 L matrix solution.
MALDI FTMS. MALDI FTMS experiments were per-
formed on a Varian/IonSpec Fourier transform mass
spectrometer (Lake Forest, CA) equipped with a 7.0-T
actively shielded superconducting magnet. The FTMS
instrument consisted of an external high-pressure
MALDI source. A 355-nm Nd:YAG laser (Laser Science,
Inc., Franklin, MA) was used to create ions that can be
accumulated in the external hexapole storage trap be-
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to the ICR cell. All mass spectra were collected in
positive ion mode. The ions were excited before detec-
tion with an RF sweep beginning at 7050 ms with a
width of 4 ms and amplitude of 150 V base to peak. The
filament and quadrupole trapping plates were initial-
ized to 15 V, and both were ramped to 1 V from 6500 to
7000 ms to reduce baseline distortion of peaks. Detec-
tion was performed in broadband mode from m/z
108.00 to 2500.00.
Capillary LC-ESI-Q-TOFMS/MS. Nanoscale LC-ESI-Q-
TOF MS/MS was performed using a Waters capillary
LC system coupled to a Q-TOF Micro mass spectrome-
ter (Waters Corp., Milford, MA). Chromatographic sep-
arations were performed on a C18 reverse phase capil-
lary column (75 m internal diameter by 150 mm
length, 3 m particle size; Micro-Tech Scientific Inc.,
Vista, CA). The mobile phases used were: water with
5% acetonitrile and 0.1% FA (A); acetonitrile with 5%
water and 0.1% FA (B); water with 0.1% FA (C). An
aliquot of 6.0 l of desalted hemolymph sample dis-
solved in 0.1% FAwas injected and loaded onto the trap
column (PepMap C18; 300 m column internal diameter
1 mm, 5 m particle size; LC Packings, Sunnyvale, CA)
using mobile phase C at a flow rate of 30 L/min for 3
min. Following this, the stream select module was
switched to position the trap column in line with the
analytical capillary column, and a linear gradient of
mobile phases A and B was initiated. A splitter was
added between the mobile phase mixer and the stream
select module to reduce the flow rate from 15 L/min
to 200 nL/min. The nanoflow ESI source conditions
were set as follows: capillary voltage 3200 V, sample
cone voltage 35 V, extraction cone voltage 1 V, source
temperature 120 °C, cone gas (N2) 10 L/h. Data depen-
dent acquisition was employed for the MS survey scan
and the selection of precursor ions and subsequent
MS/MS of the selected parent ions. The MS scan range
was from m/z 300 to 2000 and the MS/MS acquisition
was from m/z 50 to 1800. The MS/MS data were
converted to peak list file using ProteinLynx software
ver. 2.1 (Waters Corp.) and submitted for Mascot data-
base search against NCBI non-redundant protein data-
base, under taxonomy Metazoa. N-terminal acetylation
and C-terminal amidation were specified as variable
modifications. Precursor ion mass tolerance was 50
ppm, and product ion mass tolerance 0.3 Da. No
enzymatic cleavage specificity was specified.
Animals and Feeding Study
Jonah crabs, Cancer borealis, were shipped from the
Fresh Lobster Company (Gloucester, MA) and main-
tained without food in an artificial seawater tank at 12
to 13 °C for a week before use. Crabs were removed
from tank and placed on ice for 15 min for cold
anesthesia, and then hemolymph sample was collected
by inserting a 22-gauge needle attached to a 3-mLplastic syringe through the junction of the thorax and
abdomen into the pericardial chamber. After hemo-
lymph collection, the crab was returned to the tank to
recover for 2 days. Then the same crab was fed with crab
meat until it stopped eating, which took 30 to 40 min.
Hemolymph sample was collected after packing the crab
in ice for 15 min in the same way described above.
Hemolymph Sample Preparation
Different buffer systems were used to extract peptides
from freshly obtained hemolymph samples and are
listed below:
Method 1. 0.75 mL acidified methanol was spiked into
0.75 mL freshly obtained hemolymph to extract pep-
tides and precipitate large proteins.
Method 2. To inhibit protein degradation, half of a
protease inhibitor cocktail pill was dissolved in 40 mL
of 20 mM EDTA solution. A mixture of 0.45 mL
acidified methanol and 0.3 mL protease inhibitor mixed
EDTA solution was added to 0.75 mL freshly obtained
hemolymph. Protease inhibitor was added to eliminate
enzymatic protein degradation during sample prepara-
tion and EDTA can prevent cation triggered protein
clotting, which has been reported to decrease recovery
of putative peptides in the sample [19].
Method 3. 0.75 mL protease inhibitor mixed EDTA
solution was spiked into 0.75 mL freshly obtained
hemolymph. The resulting solution was then boiled for
10 min to further inhibit protease activity and precipi-
tate hemolymph proteins.
The sample prepared by each method was centri-
fuged at 16,000 rcf for 10 min; then the supernatant was
harvested and equally divided into two fractions and
filtered through a 10 kDa MWCO tube by centrifuging
at 15,000 rcf. The low mass filtrate was concentrated to
dryness using a Savant SC 110 SpeedVac concentrator
(Thermo Electron Corporation, West Palm Beach, FL)
and was resuspended in 80 L 0.1% FA in water. After
sonication for 10 min, the sample was desalted by C18
micro spin column according to the product manual
and eluted in 6 L 0.1% FA in 50% acetonitrile (vol/
vol). The sample was then directly used for MALDI MS
detection. For LC-ESI-QTOF experiment, the sample
was first dried followed by resuspension in 6 L 0.1%
FA in water before injection.
SDS-PAGE
To evaluate the protein removal efficiency of three
sample preparation methods, tricine-sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
was performed using XCell SureLock Mini-Cell (In-
vitrogen, Carlsbad, CA) according to the instruction
manual. Briefly, both crude hemolymph and processed
hemolymph samples were separated with a NuPAGE
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(Invitrogen) at 200V for 30 min. After rinsed with water,
the gel was then stained with SimplyBlue SafeStain
(Invitrogen) for 1 h, and incubated with water over-
night before visualization.
Formaldehyde Derivatization and Recovery Assay
Stable isotopic labeling with H2/D2 formaldehyde us-
ing reductive methylation was performed to measure
the concentration of internal standard in the processed
hemolymph sample, which can be used to examine the
recovery of each method. An aliquot of 6 L of the final
processed hemolymph sample was mixed with 0.75 L
borane pyridine (120 nM) and 0.5 L formaldehyde
(20%, vol/vol). Peptide standard mixture solution with
known concentration was labeled in the same way but
with deuterium formaldehyde. Both samples were in-
cubated at 37 °C for 20 min. The formaldehyde labeled
hemolymph sample was then mixed with the peptide
standard solution with 1:1 ratio. 0.4 L of the labeled
mixture was spotted and analyzed by MALDI TOF/
TOF. The recovery of each internal standard was then
calculated based on the ratio of isotopic cluster area
from light labeled standards and heavy labeled stan-
dards.
The same animal was used in each set of comparison
assay to eliminate changes induced by animal variabil-
ity and different sample background. Internal stan-
dards were spiked into fresh hemolymph samples re-
sulting in concentration of 10 or 30 nM. The sample was
prepared using three methods described in a previous
section. After processing, 0.4 L of the resulting hemo-
lymph sample was analyzed by MALDI TOF/TOF to
compare signal to noise ratio of internal standards
prepared by these three methods. Each sample was
spotted three times, and every spot was analyzed twice.
The signal to noise ratios (S/N) of internal standard
peaks were calculated by averaging six spectra.
Results and Discussion
Evaluation of Sensitivity and Peptide Coverage of
Three Sample Preparation Protocols—Peptide
Detection in Hemolymph with 10 nM Spiked
Synthetic Peptides
The sensitivity of MS detection is largely dependent on
the sample background. Without sample processing,
few peptide peaks can be detected in the crude hemo-
lymph sample due to very high concentration of salts
(more than 600 mM) and the presence of large proteins
such as clotting factors (Figure S1a, which can be found
in the electronic version of this article). The signal
intensity of spiked synthetic peptide standards in crude
hemolymph was 100 fold lower compared to standards
with the same concentration prepared in pure water
(Figure S1b, c). Therefore, removal of salts, abundant
proteins, and further concentrating the sample wascrucial to detect putative neuropeptides in hemolymph
samples.
The sensitivity of three different sample preparation
protocols described above was evaluated using peptide
standards by MALDI-TOF/TOF. Five internal standard
peptides were spiked into the original hemolymph
sample at a concentration of 10 nM, including bradyki-
nin (m/z 1060.5), [Arg8] vasopressin (AVP, m/z 1084.4),
[Val5] angiotensin I (m/z 1282.7), allatostatin I (m/z
1335.7), and substance P (m/z 1347.7). These peptides
cover mass range of 500 to 2000 Da, which is suitable for
examining preparation methods for neuropeptide de-
tection. As shown in Figure 1, all five internal standards
were detected using Method 2 with good signal inten-
sity, while AVP was not detected using Method 1 and
substance P was not detected using Method 3 (n  3).
Because acidified methanol is commonly used for neu-
ropeptide extraction, we employed this buffer to dena-
ture and precipitate the abundant proteins in hemo-
lymph and extract peptides in Method 1 and Method 2.
Methanol provides good solubility for most small pep-
tides, while the high acid concentration of this buffer
can denature large proteins including protease to pre-
vent degradation of target peptides during sample
preparation. In Method 2, EDTA solution was added to
prevent cation trigged protein clotting during the sam-
ple preparation process. Additionally, protease inhibi-
tor cocktail pill was added to further eliminate peptide
and protein degradation. In Method 3, aqueous EDTA
solution was used to extract peptides and abundant
proteins were precipitated with heat treatment, result-
ing in depletion from the hemolymph samples. To
evaluate the effectiveness of protein depletion of these
three methods, SDS-PAGE gel separation was per-
formed on various hemolymph samples before and
after treatment. As seen, all three methods can signifi-
cantly reduce the abundant protein content in the
original hemolymph samples; however the acid in-
duced precipitation is more efficient than the heating
induced precipitation (Figure S2). The resulting hemo-
lymph samples can be further simplified by ultrafiltra-
tion using a 10 kDa MWCO membrane. This treatment
can improve the matrix crystallization, eliminate ion
suppression, and may also increase the recovery of
peptides from the C18 spin column. Crustacean hemo-
lymph contains a large amount of salt, which greatly
interferes with MS detection. After desalting with C18
spin column, better spectral quality can be achieved
compared to crude samples (data not shown). In
Method 1, the detection of spiked peptide standards
was greatly interfered by polymer-like peaks in the
mass range from 500 to 1000 Da. Method 3 produced
comparable results with Method 2 showing preferential
detection of smaller peptides, such as bradykinin and
AVP, whereas peptide allatostatin was detected with
much lower peak intensity, and substance P was not
even detected using this method. This experiment
showed that the addition of small amount of organic
solvent can facilitate extraction of larger and more
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ropeptides are amidated at their C termini, increasing
their hydrophobicities, Method 2, should have better
recovery than Method 3 for detection of neuropeptides.
However, if the peptides of interest are more hydro-
philic, Method 3, employing an aqueous extraction
buffer, can also be considered as an efficient extraction
method.
Quantitative Evaluation of Recovery of Synthetic
Peptides in Hemolymph Sample
To evaluate the recovery of synthetic peptides by vari-
ous processing methods, dimethylation using isotopic
formaldehyde was performed on processed hemo-
lymph samples. In the 10 nM internal standard spiked
experiments, one peptide standard was not detected in
samples prepared by either Method 1 or Method 3,
hence the concentrations of internal peptide standards
were elevated to 30 nM for a more complete and
accurate evaluation of recovery rates of these three
sample preparation protocols. To calculate the accurate
recoveries, the final sample prepared by each method
was labeled with formaldehyde and mixed with the
same volume of 106 M peptide standard mixture
labeled with deuterium formaldehyde. This method
labels the N-termini of peptides with two methyl
groups, resulting in 4 Da mass differences between light
Figure 1. MALDI TOF/TOF spectral comparis
peptide standards at a concentration of 10 nM
methanol was used as extraction buffer. (b) Met
and protease inhibitors. (c) Method 3: extraction
heat induced protein precipitation/depletion. T
while the polymer-like peaks were labeled with
charged in this study.labeled and heavy labeled peak pair per incorporatedlabel. It has been reported as a fast and simple reaction
that can be applied for differential proteomic and
peptidomic analysis [20–22]. Figure 2 shows the result
from isotopic labeling experiment of a hemolymph
sample processed by Method 2. All of the peptide pairs
spiked in the sample were detected with good signal
intensity. The relative abundances of the internal stan-
dards in the final samples can be calculated based on
ratios of light labeled peak cluster area and heavy
labeled peak cluster area, which were further converted
to recoveries. Figure 3 compares the signal-to-noise
ratios and recoveries of different peptide standards
achieved by three sample preparation methods. Among
these three methods, Method 2 provides the best signals
for all peptides and also better recoveries for most cases,
suggesting that a combination of acidified methanol,
EDTA, and protease inhibitors provides better detection
sensitivity than the other two preparation methods. The
S/N and recovery values and their relative standard
deviation (RSD) for each method are summarized in
Table 1 (n  6). Recovery of peptide substance P is not
listed because after formaldehyde labeling, this peak is
largely interfered by isotopic peaks of m/z 1401.8
present in the hemolymph sample.
The study of several commonly used peptide stan-
dards demonstrates that Method 2 provides acceptable
recovery rates ranging from 20% to 70% depending on
the properties of specific peptides. A major source of
f hemolymph sample spiked with five internal
g three methods. (a) Method 1: pure acidified
2: acidified methanol mixed with 20 mM EDTA
20 mM EDTAmixed with protease inhibitor and
ternal standard peaks were labeled with stars,
l peaks shown in the MALDI spectra are singlyon o
usin
hod
with
he in
x. Alsample loss is due to possible adsorption and interac-
led pe
s pres
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depletion and precipitation process in all three methods
[19]. Filtration through MWCO can also contribute to
sample loss because there is usually solution remains in
Figure 2. MALDI mass spectrum of formaldehy
Equimolar ratio ofH2-formaldehyde labeledhemolym
standards weremixed and analyzed. The heavy labe
open circles, and the light labeled internal standard
circles.
Figure 3. Quantitative comparisons of three hemolymph preparation
methods spikedwith 30nM internal standards. (a) Comparisonof signal
to noise ratios of five internal peptide standards (n 6). (b) Comparison
of overall recovery of four internal peptide standards.the high molecular weight portion and the molecular
weight cutoff membrane may also absorb peptides.
Recovery of Method 1 is comparable with Method 2;
however this method yields lower S/N. This is likely
because the MS detection was greatly influenced by
sample background. As mentioned in the last section,
polymer-like peaks are commonly detected using
Method 1, which can cause poor crystallization and
suppress the detection of peptides. The recovery and
sensitivity of Method 3 are comparable with Method 2
for the two smaller peptide standards, but much worse
for the other three larger peptides, especially allatosta-
tin I and substance P, which have amidation on their C
termini, increasing their hydrophobicity. This compar-
ison shows that spiking EDTA aqueous solution and
protease inhibitor into acidified methanol is best suited
for neuropeptide detection in hemolymph sample.
Profiling and Sequencing of Neuropeptides
in Hemolymph
Five groups of hemolymph samples from both fed and
unfed Cancer borealis were processed by Method 2 and
analyzed by MALDI FTMS and MALDI TOF/TOF. As
listed in Table 2, nine known neuropeptides were
detected, including two tachykinin-related peptides
(TRP, m/z 934.5, m/z 964.5), one A-type allatostatin (m/z
967.5), an orcokinin peptide (m/z 1256.6), the crustacean
cardioactive peptide (CCAP, m/z 956.4) and four
RFamides (m/z 1104.6, m/z 1005.6, m/z 1105.6, m/z
1019.6). Due to the low intensity of these peaks present
in the hemolymph sample, some of the peptides were
assigned based on accurate mass measurement alone
without MS/MS confirmation. The threshold of mass
error was set at 50 ppm. Figure 4 shows representative
beled hemolymph sample prepared by Method 2.
ample andD2-formaldehyde labeled 10
6Mpeptide
aks from spiked peptide standards are labeledwith
ent in hemolymph sample are indicated with solidde la
ph sMALDI mass spectra of two hemolymph samples col-
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conditions. As shown in Figure 5a, CID fragmentation
spectrum of m/z 934.5 was obtained using MALDI
TOF/TOF, which indicated the amino acid sequence of
tachykinin-related peptide Ia (CabTRP Ia). For the first
time, CabTRP Ia was confirmed as a circulating hor-
mone present in the hemolymph, and this peptide was
only detected in the hemolymph sampled from unfed
animals. Another TRP detected in hemolymph was
CabTRP II (m/z 964.5), which was also seen only in the
hemolymph collected from a starved animal. This result
suggests that TRPs are released into circulating fluid
as hormones, and their concentration level is corre-
lated to the feeding status of animals with higher
abundance in circulation detected in starved animals.
TRPs have previously been reported as bioactive
neuropeptides that can activate pyloric motor pat-
terns [18]. They are present extensively in the brain,
stomatogastric nervous system (STNS), and sinus
gland (a peptide release organ in eyestalk) of several
different crustacean species [18, 23, 24]. Based on our
Table 1. Comparisons of S/N and recoveries of five neuropepti
three different methods
Internal
standards
Method 1
S/N
RSD
(%)
Recovery
(%)
RSD
(%) S/N
Angiotensin I 35 19 24 12 446
Bradykinin 84 14 13 11 545
Angiotensin II 132 17 59 5 385
Allatostatin I 276 22 52 7 1005
Substance P 199 19 N/A N/A 584
n  6.
N/A: the value is not available.
Table 2. List of native neuropeptides detected in Cancer borealis
Peptide sequence
Protonated mo
Measured
Tachykinin-related peptides
APSGFLGMRamide* 934.49
TPSGFLGMRamide 964.50
CCAP
PFcNAFTGcamide 956.44
RF amide
APRNFLRFamide 1019.56
GPRNFLRFamide 1005.61
GAHKNYLRFamide 1104.58
SMPSLRLRFamide 1105.65
A type allatostatin
ERPYSGLamide 967.50
Orcokinin
NFDEIDRSGFG 1256.56
Novel peptide
I/LNFTHKFamide* 905.49
Lower case c in the CCAP peptide sequence stands for disulfide-bond
RFamide stands for peptide family ending with Arg-Phe-amide C-term
*The presence of this peptide is confirmed by MS/MS.
x The presence of this peptide in hemolymph sample as detected by a part
peptide.recent neuropeptidomic study of neural tissue in
Cancer borealis, CabTRP Ia was detected in sinus
gland with very low abundance, whereas CabTRP II
was detected only in the brain and STNS (unpub-
lished result). Recently, these two TRPs were de-
tected as gut derived peptides present in midgut
epithelium endocrine cells at relatively high abun-
dances [18]. This observation suggests that these two
neuropeptides are very likely to be released from the
midgut epithelium. However, the underlying mech-
anism governing the release of these peptides and
how they are involved with feeding regulation re-
quires further investigation.
All of the other detected neuropeptides were previ-
ously observed in the pericardial organ or sinus gland
of Cancer borealis or other crustacean species [12, 13, 24].
It is not surprising that these neuropeptides present in
the hemolymph sample, since pericardial organ and
sinus gland are major neurohemal organs for releasing
peptide hormones into circulating fluid to affect distant
stomatogastric motor neurons. A novel peptide with
piked in the crustacean hemolymph samples prepared using
Method 2 Method 3
D
)
Recovery
(%)
RSD
(%) S/N
RSD
(%)
Recovery
(%)
RSD
(%)
5 32 6 165 19 27 7
0 22 8 448 20 24 5
3 69 6 213 12 51 3
0 64 4 113 11 14.1 4
9 N/A N/A 69 14 N/A N/A
olymph
topic mass
TOF/TOF FTMSTheoretical
934.49 x
964.50 x
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1005.57 x
1104.61 x
1105.63 x
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1256.55 x
905.50 x x
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equence.des s
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2
2
1
2hem
noiso
forma
inal sicular instrument. CCAP is an abbreviation for crustacean cardioactive
uence
715J Am Soc Mass Spectrom 2009, 20, 708–718 NEUROPEPTIDE ANALYSIS IN CRUSTACEAN HEMOLYMPHmass of 905.50 Da was also identified in this study using
MALDI TOF/TOF, resulting in a deduced sequence of
I/LNHTHKFamide. As shown in Figure 6a, the MS/MS
fragment ion spectrum of this peptide was obtained by
MALDI TOF/TOF directly from processed hemo-
lymph sample. To further confirm the presence of
lysine residue in this peptide, the hemolymph sample
was derivatized with formaldehyde. The MS/MS
spectrum of dimethyl labeled form of this peptide as
shown in Figure 6b indicates that there are two
labeled sites in this peptide, including N terminus
and a lysine residue near the C terminus. The iden-
tification and derivation of the amino acid sequence
of the new peptide was further confirmed by the
tandem MS fragmentation analysis of synthetic pep-
tide standard (Figure 6c) and its dimethylated
counterpart (Figure 6d). As shown, identical frag-
mentation patterns and fragment ions were detected
from synthesized standard. Given that the C-terminal
amidation is a conserved post-translational modifica-
tion (PTM) for most neuropeptides and the similarity
of the amino acid residue components of this peptide
to the well known RFamides, this peptide is likely to
belong to a new family of neuropeptide(s). Electro-
Figure 4. Comparisons of the hemolymph pep
starved and satiated conditions via MALDI T
spectrum of hemolymph from crab under star
hemolymph from the same crab under satiate
degradation products are labeled with their seqphysiology experiments will be performed in thefuture to further evaluate and confirm the biological
function of this peptide.
Identification of Peptides from Abundant
Protein Degradation
With MS/MS information obtained with MALDI TOF/
TOF and LC-ESI-QTOF, several abundant peaks in the
hemolymph peptidomic profile were identified as pro-
tein degradation products (shown in Figure 5b). As
shown in Table 3, a series of these protein degradation
fragments come from a molting protein cryptocyanin,
which has similar structure and sequence as hemocya-
nin but has no function of oxygen transporting. This
protein was characterized in Cancer magister and was
reported to be at even higher concentration than hemo-
cyanin at certain molting stages [25]. Huybrechts et al.
previously suggested the contamination of these puta-
tive cryptocyanin fragments by mass measurements in
the analysis of Cancer borealis brain and thoracic ganglia
extracts [26]. In this study, MS/MS fragmentation anal-
yses obtained by LC-ESI-QTOF were used to derive the
sequences of these peaks (data not shown), and their
ic profiles acquired from the same crab under
TOF using Method 2. (a) MALDI TOF/TOF
condition. (b) MALDI TOF/TOF spectrum of
ndition. Neuropeptides and identified protein
s or peptide names.tidom
OF/
ved
d coidentities were confirmed with BLAST search. Several
ing a
716 CHEN ET AL. J Am Soc Mass Spectrom 2009, 20, 708–718of these cryptocyanin degradation fragments have sim-
ilar masses with some known neuropeptides, such as
m/z 1395.7 and m/z 1281.7, which may lead to mis-
assignment of these peaks. Careful attention is therefore
needed to distinguish protein degradation products
from putative neuropeptides with similar masses.
Another protein degradation product was identified
with m/z 1209.7 (Figure 5b). This peptide was detected
as an abundant peak in the fed crab’s hemolymph
(Figure 4b). To determine its identity, MS/MS fragmen-
tation was obtained on MALDI TOF/TOF shown in
Figure 5b. The sequence was deduced manually as-
sisted by de novo Explorer software. LC-ESI-QTOF data
were submitted for Mascot database search, resulting in
the sequence assignment of LRVAPEESPVL, which was
shown to be a fragment of actin in several different
crustacean species, such as Gecarcinus lateralis and
Penaeus monodon. Mascot search with LC-ESI-QTOF
data also showed several other fragments from actin,
Figure 5. MALDI TOF/TOF tandem MS seque
degradation fragment (m/z 1209.7) from the hem
peptide is given above the spectrum. The prese
above (b ions) or below (y ions) the correspondbut they were present at lower abundances and wereusually not detected in MALDI MS. Enzymatic degra-
dation of proteins can occur under natural conditions or
during sample processing, which can be eliminated by
immediate denaturing of the degradation enzymes in
fresh hemolymph samples using acid extraction and/or
adding protease inhibitors. Different degradation prod-
ucts are observed for different sample preparation
methods, which may be due to their different solubili-
ties and different enzyme activities in different solvent
environments. Due to the lack of sequenced genome for
crustacean species the complete characterization of pro-
tein degradation products in hemolymph was not at-
tempted.
Although less abundant protein degradation prod-
ucts have been reported using in vivo microdialysis
sampling approach where degradation enzymes have
been filtered out with molecular weight cutoff mem-
brane [27], the direct analysis of hemolymph samples
using methods described in this study represents an
g of (a) CabTRP 1a (m/z 934.49) and (b) protein
ph sample. The amino acid sequence of each
f b and y ions is indicated by horizontal lines
mino acid residues in the peptide sequence.ncin
olym
nce oattractive alternative strategy that offers simplicity,
717J Am Soc Mass Spectrom 2009, 20, 708–718 NEUROPEPTIDE ANALYSIS IN CRUSTACEAN HEMOLYMPHspeed, and throughput. Without the need to perform
animal surgery and sophisticated microdialysis probe
implantation, direct neuropeptide analysis using crude
hemolymph extraction allows collection and concentra-
tion of a large-volume of hemolymph in a short amount
of time, which enables detection and sequencing of
neuropeptides present at much lower abundance in
circulating fluids. The combination of two different
strategies of neuropeptide detection in hemolymph will
offer unprecedented information of neuropeptidomes
in complex circulating environment under different
physiological conditions.
Conclusions
This study reported and established an effective
method of neuropeptide analysis in circulating fluids
Figure 6. MS/MS sequencing of a novel pep
MALDI TOF/TOF. (a) MS/MS of putative pep
deduced sequence of I/LNFTHKFamide. (b)
LNFTHKFamide at a concentration of 10 M. (c)
at m/z 961.56 in hemolymph sample. Asterisks
terminus and the lysine residue. (d) MS/MS of f
with a sequence of LNFTHKFamide at a concent
labeled sites, including N terminus and the lysin
by horizontal lines above (b ions) or below (y
peptide sequence.
Table 3. Abundant protein degradation products detected in
hemolymph sample
Proteins [M  H] Sequence
Cryptocyanin 1508.81 YKIFEPLRESNL
1395.73 YKIFEPLRESN
1281.68 YKIFEPLRES
1194.65 YKIFEPLRE
1065.61 YKIFEPLR-Actin 1209.68 LRVAPEESPVLcollected from a marine organism. Through compar-
ison of three different extraction buffer systems and
two different abundant protein depletion methods,
the use of acidified methanol and protease inhibitor
was shown to be efficient for trace-level neuropeptide
analysis in hemolymph samples. For the first time,
CabTRP Ia was detected directly in crustacean hemo-
lymph sample using MS with confident MS/MS
sequence confirmation. Furthermore, the involve-
ment of tachykinin-related peptides in feeding regu-
lation was revealed in this work. A novel peptide
with C-terminal KFamide was characterized directly
from hemolymph sample. Finally, protein fragments
in hemolymph sample were identified with combina-
tion of de novo sequencing, database search, and
BLAST. Collectively, our study represents the first
comprehensive peptidomic analysis of Cancer borealis
hemolymph. The methodology developed in this
study will find applications in expanding peptidomes
in many important biological fluids derived from
other model systems.
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